Literature DB >> 9517777

Influence of antirheumatic drugs on nitric oxide and interleukin 8 production in human articular chondrocytes.

C M De Gendt1, L S De Clerck, C H Bridts, A Verbruggen, W J Stevens.   

Abstract

OBJECTIVE: To determine whether antirheumatic drugs can inhibit chondrocyte nitric oxide and interleukin 8 (IL-8) production.
METHODS: IL-1beta stimulated human chondrocytes were incubated with indomethacin, methotrexate, sulfasalazine, dexamethasone, and methylprednisolone. Nitric oxide was detected as nitrite; IL-8 was detected by a radioimmunoassay method.
RESULTS: Nitric oxide production was partly (< or = 50%) inhibited and IL-8 almost completely suppressed (> 80%) by dexamethasone and methylprednisolone. Sulfasalazine in pharmacological concentration and indomethacin slightly increased IL-8. No effect of methotrexate on nitric oxide or IL-8 production was found.
CONCLUSION: Dexamethasone and methylprednisolone are inhibitors of human chondrocyte nitric oxide production, although to a lesser extent than for IL-8 production. Indomethacin, sulfasalazine, and methotrexate had no major influence on these mediators.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9517777

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  3 in total

1.  Sulphasalazine inhibits macrophage activation: inhibitory effects on inducible nitric oxide synthase expression, interleukin-12 production and major histocompatibility complex II expression.

Authors:  G Haskó; C Szabó; Z H Németh; E A Deitch
Journal:  Immunology       Date:  2001-08       Impact factor: 7.397

2.  Effects of methotrexate upon inflammatory parameters induced by carrageenan in the mouse model of pleurisy.

Authors:  Eduardo Monguilhott Dalmarco; Tânia Silvia Fröde; Yara Santos Medeiros
Journal:  Mediators Inflamm       Date:  2002-10       Impact factor: 4.711

3.  Nitric oxide levels and the severity of juvenile idiopathic arthritis.

Authors:  Blanca Elena R G Bica; Niele M Gomes; Patrícia D Fernandes; Ronir R Luiz; Vera Lúcia G Koatz
Journal:  Rheumatol Int       Date:  2007-02-08       Impact factor: 3.580

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.